Portal Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Portal Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion [Phase 2]
Phase 2 trial evaluating proton beam radiotherapy followed by atezolizumab (Tecentriq) and bevacizumab (Avastin) for hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis [Phase 4]
Phase 4 pharmacokinetic study of apixaban to prevent portal hypertension complications in cirrhosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD [NA]
A clinical trial is evaluating the efficacy of apixaban for portal vein thrombosis occurring more than one year after liver disease in patie…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT [Phase 2]
A completed Phase 2 trial evaluating hepatic arterial infusion chemotherapy combined with Lenvatinib and PD-1 inhibitors for advanced hepato…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
This completed clinical trial evaluates portal vein stenting for malignant obstruction, reporting on feasibility and safety and detailing ob…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Intraoperative Endovascular Treatment Via the Ligamentum Teres Hepatis in Liver Transplantation for Yerdel Grade Ⅲ/IV Portal Vein Thrombosis: A Safe and Effective Strategy
A completed clinical trial evaluating intraoperative endovascular treatment via the ligamentum teres hepatis during liver transplantation in…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause.
Completed clinical trial investigating risk factors for recurrence or extension of thrombosis in acute non-cirrhotic portal vein thrombosis …
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） [Phase 4]
A Phase 4 trial assessed whether apixaban, warfarin, and aspirin can prevent portal vein thrombosis after laparoscopic splenectomy in patien…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy [Phase 2]
A Phase 2 neoadjuvant trial comparing atezolizumab/bevacizumab versus neoadjuvant radiation therapy in hepatocellular carcinoma with portal …
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis [Phase 2]
Phase 2 trial comparing sorafenib plus hepatic arterial infusion versus sorafenib alone in hepatocellular carcinoma with major portal vein t…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis [Phase 2]
A Phase 2 clinical trial evaluating H101 in combination with transarterial chemoembolization (TACE) for primary hepatocellular carcinoma wit…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT [Phase 3]
Phase 3 trial comparing SBRT+TACE+Sorafenib versus Sorafenib alone in unresectable hepatocellular carcinoma with portal vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Safety of Anticoagulant Therapy After Endoscopic Treatment [Phase 4]
Phase 4 trial update assessing the safety of anticoagulant therapy after endoscopic treatment in patients with cirrhosis and portal vein thr…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. [Phase 3]
Phase 3 trial updating on the prevention of recurrent thrombosis with Xarelto compared to no treatment in patients with chronic portal vein …
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis [Phase 4]
Phase 4 clinical trial updating the efficacy and safety of anticoagulant therapy in patients with portal vein thrombosis and liver cirrhosis…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection [Phase 4]
A Phase 4 clinical trial reports that warfarin prevents portal vein thrombosis after laparoscopic splenectomy with azygoportal disconnection…
-
CLINICAL_TRIALS trial_result · 2018-11-27Clinical Trial Update: Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study [Phase 3]
Pilot prospective cohort study evaluating rivaroxaban for treatment of splanchnic vein thrombosis including portal, mesenteric, and splenic …
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis [Phase 3]
Phase 3 clinical trial evaluating rivaroxaban for efficacy and safety in acute non-neoplastic portal vein thrombosis in compensated cirrhosi…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV [NA]
This clinical trial update reports on the efficacy and safety of rivaroxaban for acute non-neoplastic portal vein thrombosis in patients wit…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis [Phase 3]
Phase 3, placebo-controlled study of NPB-06 in portal vein thrombosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of combining radiotherapy and hyperthermia after transarterial chemoembolization in he…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV [Phase 3]
Phase 3 trial update evaluating transjugular intrahepatic portosystemic shunt (TIPS) to prevent variceal rebleeding in cirrhotic patients wi…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis [Phase 4]
This document provides a Phase 4 clinical trial update evaluating the effect of anticoagulation after endoscopic therapy in patients with ci…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis
This clinical trial update reports on how prevalent portal vein thrombosis is among patients with liver cirrhosis and identifies factors tha…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding [Phase 3]
A Phase 3 clinical trial evaluates whether adding a statin to standard therapy reduces recurrent hemorrhage in patients with cirrhosis and p…